-
1
-
-
70449633330
-
-
Ministry of Health, Labor and Welfare Accessedon24April2009
-
Ministry of Health, Labor and Welfare (2009) National Health and Nutrition Survey in 2007. www.mhlw.go.jp/houdou/2008/12/h1225-5.html. Accessed on 24 April 2009
-
(2009)
National Health and Nutrition Survey in 2007
-
-
-
2
-
-
0034534774
-
Fibrinogen, other cardiovascular risk factors and diabetes mellitus in Hong Kong: A community with high prevalence of Type 2 diabetes mellitus and impaired glucose tolerance
-
DOI 10.1046/j.1464-5491.2000.00384.x
-
TH Lam LJ Liu ED Janus KSL Lam AJ Hedley 2000 Fibrinogen, other cardiovascular risk factors and diabetes mellitus in Hong Kong Chinese: a community with high prevalence of type 2 diabetes mellitus and impaired glucose tolerance Diabetic Med 17 798 806 11131105 10.1046/j.1464-5491.2000.00384.x 1:STN:280:DC%2BD3M7jslanug%3D%3D (Pubitemid 32000979)
-
(2000)
Diabetic Medicine
, vol.17
, Issue.11
, pp. 798-806
-
-
Lam, T.H.1
Liu, L.J.2
Janus, E.D.3
Lam, K.S.L.4
Hedley, A.J.5
-
3
-
-
0035856920
-
Global and societal implications of the diabetes epidemic
-
DOI 10.1038/414782a
-
P Zimmet KG Alberti J Shaw 2001 Global and societal implications of the diabetes epidemic Nature 414 6865 782 787 11742409 10.1038/414782a 1:CAS:528:DC%2BD38Xhtlymtg%3D%3D (Pubitemid 34000780)
-
(2001)
Nature
, vol.414
, Issue.6865
, pp. 782-787
-
-
Zimmet, P.1
Alberti, K.G.M.M.2
Shaw, J.3
-
4
-
-
82455200902
-
Excerpts from the United States Renal Data System 2008 Annual Data Report: International comparison
-
United States Renal Data System
-
United States Renal Data System (2009) Excerpts from the United States Renal Data System 2008 Annual Data Report: International comparison. Am J Kidney Dis 53(Suppl 1):S297-S308
-
(2009)
Am J Kidney Dis
, vol.53
, Issue.SUPPL 1
-
-
-
5
-
-
84855294188
-
-
Japanese Society of Dialysis Therapy: An overview of regular dialysis treatment in Japan as of Dec 31, 2007 Accessed24April2009
-
Japanese Society of Dialysis Therapy: An overview of regular dialysis treatment in Japan as of Dec 31, 2007. http://docs.jsdt.or.jp/overview/. Accessed 24 April 2009
-
-
-
-
7
-
-
47649091344
-
Microvascular disease: What does the UKPDS tell us about diabetic nephropathy?
-
DOI 10.1111/j.1464-5491.2008.02496.x
-
R Bilous 2008 Microvascular disease: what does the UKPDS tell us about diabetic nephropathy? Diabet Med 25 Suppl 2 25 29 18717975 10.1111/j.1464-5491. 2008.02496.x (Pubitemid 352020092)
-
(2008)
Diabetic Medicine
, vol.25
, Issue.SUPPL. 2
, pp. 25-29
-
-
Bilous, R.1
-
8
-
-
0033852481
-
Preserving renal function in adults with hypertension and diabetes: A consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group
-
10977801 10.1053/ajkd.2000.16225 1:STN:280:DC%2BD3cvjsFSqsw%3D%3D
-
GL Bakris M Williams L Dworkin, et al. 2000 Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group Am J Kidney Dis 36 646 661 10977801 10.1053/ajkd.2000.16225 1:STN:280: DC%2BD3cvjsFSqsw%3D%3D
-
(2000)
Am J Kidney Dis
, vol.36
, pp. 646-661
-
-
Bakris, G.L.1
Williams, M.2
Dworkin, L.3
-
9
-
-
0035922441
-
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
-
11565518 10.1056/NEJMoa011161 1:CAS:528:DC%2BD3MXntlelsLk%3D
-
BM Brenner ME Cooper D de Zeeuw, et al. 2001 Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 861 869 11565518 10.1056/NEJMoa011161 1:CAS:528: DC%2BD3MXntlelsLk%3D
-
(2001)
N Engl J Med
, vol.345
, pp. 861-869
-
-
Brenner, B.M.1
Cooper, M.E.2
De Zeeuw, D.3
-
10
-
-
0035922447
-
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
-
11565517 10.1056/NEJMoa011303 1:CAS:528:DC%2BD3MXntlelsLg%3D
-
EJ Lewis LG Hunsicker WR Clarke, et al. 2001 Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 851 860 11565517 10.1056/NEJMoa011303 1:CAS:528:DC%2BD3MXntlelsLg%3D
-
(2001)
N Engl J Med
, vol.345
, pp. 851-860
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Clarke, W.R.3
-
11
-
-
12144286279
-
Renin Angiotensin Aldosterone System Blockade and Renal Disease in Patients with Type 2 Diabetes: An Asian perspective from the RENAAL study
-
DOI 10.2337/diacare.27.4.874
-
JC Chan NM Wat WY So, et al. 2004 Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study Diabetes Care 27 874 879 15047641 10.2337/diacare.27.4.874 1:CAS:528:DC%2BD2cXjsFegsrw%3D (Pubitemid 38420207)
-
(2004)
Diabetes Care
, vol.27
, Issue.4
, pp. 874-879
-
-
Chan, J.C.N.1
Wat, N.2
So, W.-Y.3
Lam, K.S.L.4
Chua, C.-T.5
Wong, K.-S.6
Morad, Z.7
Dickson, T.Z.8
Hille, D.9
Zhang, Z.10
Cooper, M.E.11
Shahinfar, S.12
Brenner, B.M.13
Kurokawa, K.14
-
12
-
-
33749356700
-
Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: A subanalysis of Japanese patients from the RENAAL study
-
DOI 10.1007/s10157-006-0427-6
-
K Kurokawa JC Chan ME Cooper WF Keane S Shahinfar Z Zhang 2006 Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL Study Clin Exp Nephrol 10 193 200 17009077 10.1007/s10157-006-0427-6 1:CAS:528: DC%2BD28XhtFOrsbfK (Pubitemid 44496891)
-
(2006)
Clinical and Experimental Nephrology
, vol.10
, Issue.3
, pp. 193-200
-
-
Kurokawa, K.1
Chan, J.C.N.2
Cooper, M.E.3
Keane, W.F.4
Shahinfar, S.5
Zhang, Z.6
-
13
-
-
33646919559
-
Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine
-
DOI 10.1136/bmj.38803.528113.55
-
SE McDowell JJ Coleman RE Ferner 2006 Systemic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine BMJ 332 1177 1181 16679330 10.1136/bmj.38803.528113.55 1:CAS:528:DC%2BD28XmtFamt7Y%3D (Pubitemid 44365446)
-
(2006)
British Medical Journal
, vol.332
, Issue.7551
, pp. 1177-1180
-
-
McDowell, S.E.1
Coleman, J.J.2
Ferner, R.E.3
-
14
-
-
49149087718
-
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET Study): A multicentre, randomised, double-blind, controlled trial
-
18707986 10.1016/S0140-6736(08)61236-2 1:CAS:528:DC%2BD1cXpvFKgsLs%3D
-
JF Mann RE Schmieder M McQueen, et al. 2008 Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET Study): a multicentre, randomised, double-blind, controlled trial Lancet 372 547 553 18707986 10.1016/S0140-6736(08)61236-2 1:CAS:528:DC%2BD1cXpvFKgsLs%3D
-
(2008)
Lancet
, vol.372
, pp. 547-553
-
-
Mann, J.F.1
Schmieder, R.E.2
McQueen, M.3
-
15
-
-
77953395873
-
CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials
-
the CONSORT Group
-
KF Schwaltz DG Altman D Moher the CONSORT Group 2010 CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials Ann Intern Med 152 726 732
-
(2010)
Ann Intern Med
, vol.152
, pp. 726-732
-
-
Schwaltz, K.F.1
Altman, D.G.2
Moher, D.3
-
16
-
-
33750209033
-
Olmesartan Reducing Incidence of Endstage Renal Disease in Diabetic Nephropathy trial (ORIENT): Rationale and study design
-
E Imai S Ito M Haneda JC Chan H Makino 2006 Olmesartan Reducing Incidence of Endstage Renal Disease in Diabetic Nephropathy Trial (ORIENT): rationale and study design Hypertens Res 29 703 709 17249526 10.1291/hypres.29.703 1:CAS:528:DC%2BD28XhtlartrfK (Pubitemid 44605369)
-
(2006)
Hypertension Research
, vol.29
, Issue.9
, pp. 703-709
-
-
Imai, E.1
Ito, S.2
Haneda, M.3
Chan, J.C.N.4
Makino, H.5
-
17
-
-
0030818790
-
Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: A meta-analysis of randomized trials
-
I Giatras J Lau AS Levey 1997 Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group Ann Intern Med 127 337 345 9273824 1:CAS:528:DyaK2sXmt1Wksb4%3D (Pubitemid 27362741)
-
(1997)
Annals of Internal Medicine
, vol.127
, Issue.5
, pp. 337-345
-
-
Giatras, I.1
Lau, J.2
Levey, A.S.3
-
18
-
-
0000336139
-
Regression models and life-tables
-
DR Cox 1972 Regression models and life-tables J R Stat Soc [B] 34 187 220
-
(1972)
J R Stat Soc [B]
, vol.34
, pp. 187-220
-
-
Cox, D.R.1
-
19
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
10.2307/2281868
-
EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481 10.2307/2281868
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
20
-
-
0034585310
-
The losartan renal protection study-rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the AngiotensinII Antagonist Losartan)
-
11967819 10.3317/jraas.2000.062 1:CAS:528:DC%2BD3MXhsFGktb0%3D
-
BM Brenner ME Cooper D de Zeeuw, et al. 2000 The losartan renal protection study-rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the AngiotensinII Antagonist Losartan) J Renin Angiotensin Aldosterone Syst 1 328 335 11967819 10.3317/jraas.2000.062 1:CAS:528:DC%2BD3MXhsFGktb0%3D
-
(2000)
J Renin Angiotensin Aldosterone Syst
, vol.1
, pp. 328-335
-
-
Brenner, B.M.1
Cooper, M.E.2
De Zeeuw, D.3
-
21
-
-
34249899918
-
Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes
-
DOI 10.2337/dc06-1998
-
H Makino M Haneda T Babazono, et al. 2007 Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes Diabetes Care 30 1577 1578 17389334 10.2337/dc06-1998 1:CAS:528: DC%2BD2sXntlWkt7g%3D (Pubitemid 46871174)
-
(2007)
Diabetes Care
, vol.30
, Issue.6
, pp. 1577-1578
-
-
Makino, H.1
Haneda, M.2
Babazono, T.3
Moriya, T.4
Ito, S.5
Iwamoto, Y.6
Kawamori, R.7
Takeuchi, M.8
Katayama, S.9
-
22
-
-
34249905442
-
Reduction of microalbuminuria in patients with type 2 diabetes. The Shiga Microalbuminuria Reduction Trial (SMART)
-
DOI 10.2337/dc06-2493
-
T Uzu M Sawaguchi H Maegawa A Kashiwagi 2007 Reduction of microalbuminuria in patients with type 2 diabetes: the Shiga Microalbuminuria Reduction Trial (SMART) Diabetes Care 30 1581 1583 17363751 10.2337/dc06-2493 (Pubitemid 46871176)
-
(2007)
Diabetes Care
, vol.30
, Issue.6
, pp. 1581-1583
-
-
Kashiwagi, A.1
-
23
-
-
0037031270
-
Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: A blood pressure-independent effect
-
DOI 10.1161/01.CIR.0000024416.33113.0A
-
G Viberti NM Wheeldon 2002 Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect Circulation 106 672 678 12163426 10.1161/01.CIR.0000024416.33113.0A 1:CAS:528:DC%2BD38XmvFSmsL8%3D (Pubitemid 34851925)
-
(2002)
Circulation
, vol.106
, Issue.6
, pp. 672-678
-
-
Viberti, G.1
Wheeldon, N.M.2
-
24
-
-
0034627208
-
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The Candesartan and Lisinopril Microalbuminuria (CALM) Study
-
11110735 10.1136/bmj.321.7274.1440 1:CAS:528:DC%2BD3MXjsFCkuw%3D%3D
-
CE Mogensen S Neldam I Tikkanen, et al. 2000 Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the Candesartan and Lisinopril Microalbuminuria (CALM) Study BMJ 321 7274 1440 1444 11110735 10.1136/bmj.321.7274.1440 1:CAS:528:DC%2BD3MXjsFCkuw%3D%3D
-
(2000)
BMJ
, vol.321
, Issue.7274
, pp. 1440-1444
-
-
Mogensen, C.E.1
Neldam, S.2
Tikkanen, I.3
-
25
-
-
0035922444
-
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
-
11565519 10.1056/NEJMoa011489 1:CAS:528:DC%2BD3MXntlelsLY%3D
-
H-H Parving H Lehnert J Brochner-Mortensen R Gomis S Andersen P Arner 2001 The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes N Engl J Med 345 870 878 11565519 10.1056/NEJMoa011489 1:CAS:528:DC%2BD3MXntlelsLY%3D
-
(2001)
N Engl J Med
, vol.345
, pp. 870-878
-
-
Parving, H.-H.1
Lehnert, H.2
Brochner-Mortensen, J.3
Gomis, R.4
Andersen, S.5
Arner, P.6
-
26
-
-
42049107348
-
Telmisartan, ramipril, or both in patients at high risk for vascular events
-
DOI 10.1056/NEJMoa0801317
-
S Yusuf KK Teo J Pogue, et al. 2008 Telmisartan, ramipril, or both in patients at high risk for vascular events N Engl J Med 358 1547 1559 18378520 10.1056/NEJMoa0801317 1:CAS:528:DC%2BD1cXksF2isLs%3D (Pubitemid 351522739)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.15
, pp. 1547-1559
-
-
Yusuf, S.1
Teo, K.K.2
Pogue, J.3
Dyal, L.4
Copland, I.5
Schumacher, H.6
Dagenais, G.7
Sleight, P.8
Anderson, C.9
-
27
-
-
20544436649
-
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
-
DOI 10.1056/NEJMoa043938
-
SD Solomon S Zelenkofske JJ McMurray, et al. 2005 Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both N Engl J Med 23 352 2581 2588 10.1056/NEJMoa043938 (Pubitemid 41007844)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.25
, pp. 2581-2588
-
-
Solomon, S.D.1
Zelenkofske, S.2
McMurray, J.J.V.3
Finn, P.V.4
Velazquez, E.5
Ertl, G.6
Harsanyi, A.7
Rouleau, J.L.8
Maggioni, A.9
Kober, L.10
White, H.11
Van De Werf, F.12
Pieper, K.13
Califf, R.M.14
Pfeffer, M.A.15
-
28
-
-
0035818884
-
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
-
DOI 10.1056/NEJMoa010713
-
JN Cohn G Tognoni 2001 A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 6 345 1667 1675 10.1056/NEJMoa010713 (Pubitemid 33126822)
-
(2001)
New England Journal of Medicine
, vol.345
, Issue.23
, pp. 1667-1675
-
-
Cohn, J.N.1
Tognoni, G.2
-
29
-
-
0041408235
-
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-added trial
-
DOI 10.1016/S0140-6736(03)14283-3
-
JJ McMurray J Ostergren K Swedberg, et al. 2003 Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Lancet 362 767 771 13678869 10.1016/S0140-6736(03)14283-3 1:CAS:528: DC%2BD3sXntVGktLo%3D (Pubitemid 37093916)
-
(2003)
Lancet
, vol.362
, Issue.9386
, pp. 767-771
-
-
McMurray, J.J.V.1
Ostergren, J.2
Swedberg, K.3
Granger, C.B.4
Held, P.5
Michelson, E.L.6
Olofsson, B.7
Yusuf, S.8
Pfeffer, M.A.9
|